Orio Therapeutics obtains the CHF 150’000 Kick to redefine regenerative medicine through protein engineering
Orio Therapeutics, based at BioArk Monthey, modifies therapeutic proteins using a patented technology. This modification improves drug delivery by controlling the localization of the protein after injection. Its approach ensures enhanced efficacy and reduced dosage, addressing the limitations of uncontrolled drug delivery in protein-based therapeutics. The startup received the CHF 150,000 investment from Venture Kick.